Mallinckrodt Pharmaceuticals · 4 hours ago
Senior Director, Clinical Development
Mallinckrodt Pharmaceuticals is seeking a Senior Director of Clinical Development who will provide expert clinical advice across all phases of clinical research. The role involves oversight of clinical development execution, leading multiple clinical study programs, and serving as the primary contact between internal teams and external stakeholders.
Biotechnology
Responsibilities
Acts as the lead clinical representative on Project Teams
Act as the key contributor in development of clinical development strategy across multiple indications
Develop, review, guide and approve protocols, and amendments, ICFs, and clinical sections of other documents
Oversee safety monitoring of ongoing clinical studies under their leadership with appropriate support as needed
Interact and lead engagements with thought leaders within the respective therapeutic area/indication
Track with Program Management the CD deliverables across all clinical studies/projects
Lead identifying, contracting and engaging subject matter experts/thought leaders in advisory board meetings, consultancy etc
Oversee regular maintenance and update of the CD project folders/drives
Reviews the informed consent form (ICF); ensures alignment with the related safety sections of the study protocol
Develops, reviews and/or approves clinical and safety and monitoring CRF pages
Act as the key contributor in development of clinical development strategy across multiple indications
Collaborates in study team meetings, data monitoring committee and steering committees as necessary
Helps to identify additional opportunities within the broad R&D portfolio; propose indications and study design approaches for establishing proof of concept and help to identify and evaluate opportunities for in-licensing or mergers/acquisitions that would expand the platform portfolio
Review, guide and finalize study documents such as Protocol Synopses, Protocols, Protocol amendments, Administrative Change letters etc
Ensure CD contributions to trial-related documents such as the IBs, ICF, CRFs, CRF Completion Guidelines, Study Execution and Monitoring Plans, Clinical Data Review Plan, Clinical Database specifications, statistical analysis plan, the data management plan, the safety management plan, the medical monitoring plan, Clinical Study Report (CSR) etc
Ensure regular and ad-hoc data reviews and interpretation; preparation of summaries/documentations of these reviews to Leadership
Ensure timely development of program-level documents, including, but not limited to, abstract and manuscripts, presentations, and various other internal and external documents and communications as needed
Work collaboratively with the clinical study team and other team members to prepare abstracts, manuscripts and presentations for external meetings as well as author clinical sections of regulatory documents (CSRs, IBs, IND sections, CTAs, ISS and ISE sections and clinical expert reports)
In collaboration with the Development Operations staff, develops the operational strategies for clinical research studies and development programs including, but not limited to, PI selection, CRO selection, budgets, and timelines
Ensure CD participation in vendor selection, specification development, and management/oversight, as needed
Ensure development of study specific training materials for study team, investigational sites, and vendors
Participate and present at Investigator meetings or similar
Lead the responses to scientific and data-related queries
Collaborate with statistician in data review and interpretations
Act as the primary medical monitor with support as required to identify any trial-related safety trends, and as needed, generate reports to interpret, analyze and summarize the data and trends
Develop and/or review narratives for AEs/SAEs/AESIs as necessary
Collaborate with the statistician to identify any trial-related efficacy trends, and as needed, generate reports to interpret, analyze and summarize the data and trends
Qualification
Required
Board licensed MD (or equivalent foreign qualification) in Immunology
Minimum of 8-10 years of Clinical Development experience (pharma, CRO) in Immunology/Autoimmunity
Previous experience designing and developing phase 1-4 protocols
Demonstrates ability to analyze and interpret data, assess clinical relevance and present/report findings (e.g., ISS, ISE, competitor data, etc.)
Experience working on a matrix cross-functional clinical team
Strong analytical skills; a strategic thinker, planner and implementer; proven negotiating track record
Solid Medical/Scientific writing skills required with appropriate clinical, scientific and medical knowledge to author and design and implement clinical protocol and other study documents
Working knowledge of statistics, data analysis and data interpretation
Experience with the operation aspects of clinical trials and related activities such as investigator meetings, DSMB's and GCP/ICH are necessary
Excellent written and oral communication skills
Organizational and cross functional collaboration skills
Proficient in Microsoft Office Suite of Programs
Strong interpersonal and communication skills (verbal and written) bridging scientific and business needs, integrating clinical science, disease area knowledge, and operational requirements
Incumbent must be able to work with colleagues at all levels of responsibility and authority
Ability to work on multiple projects with aggressive timelines
Action oriented, flexible, able to adapt to changes in priorities, projects, and daily activities
Strong presentation skills
Strong MSP skills
Up to 20% travel
Preferred
Therapeutic area experience preferred (demonstrable with 2 or more years relevant experience)
Previous project management/clinical operations experience desirable
Benefits
Competitive pay and benefits
This position is eligible for a bonus in accordance with the terms of the applicable program. Bonuses are awarded at the Company’s discretion.
Company
Mallinckrodt Pharmaceuticals
Mallinckrodt Pharmaceuticals combined with Endo in 2025 to better serve customers and improve outcomes for the patients we support.
Funding
Current Stage
Public CompanyTotal Funding
unknown2013-07-01IPO
Recent News
2025-11-12
Company data provided by crunchbase